Komipharm International Co (XKRX:041960) Net Income (Continuing Operations) : ₩13,864 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Komipharm International Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₩-126 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩13,864 Mil.

Komipharm International Co Net Income (Continuing Operations) Historical Data

The historical data trend for Komipharm International Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Net Income (Continuing Operations) Chart

Komipharm International Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-3,956.60

-5,934.36

-7,479.70

-5,910.61

14,690.12

Komipharm International Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															700.13	4,836.09	8,911.65	242.25	-126.22

Komipharm International Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,864 Mil.

Komipharm International Co (XKRX:041960) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Komipharm International Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Komipharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450

Website

http://www.komilab.co.kr

Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines